The African Aids Epidemic By John Iliffe Video
The AIDS Epidemic Sweeping Across Zimbabwe (1999) The African Aids Epidemic By John Iliffe
Test samples had to be sent more than 1, kilometres from remote hospitals to the capital Kinshasa. Results took weeks to come back. Some of the infected returned home, spreading the virus.
In Bukavu, the capital of South Kivu province, bodies piled up in the morgue. Senior doctors described total confusion. Five doctors and 10 nurses were among those who died, according to one medic who spoke on condition of anonymity. It needn't have been this way. Bukavu's Provincial General Reference Hospital, like dozens of others across Congo, had access to a machine that could have processed around COVID tests a day, if only it had the right chemical kits, doctors there told Reuters. In late March, California-based diagnostics firm Cepheid, article source unit of industrial conglomerate Danaher The African Aids Epidemic By John Iliffe, began supplying a rapid and highly accurate COVID test that seemed perfectly suited to Congo's needs.
Nearly 5, of Cepheid's GeneXpert diagnostic devices were already deployed in health facilities across Africa as part of the battle against tuberculosis TBEbola, HIV and other infectious diseases. There were of the devices in Congo alone. Staff would need little training to pivot to testing for Epodemic, and results would be ready in hours, not weeks. Starting indonor organizations put their faith in Cepheid equipment to help tackle deadly diseases in countries that lack medical laboratories and skilled personnel to run them. The U. The reason: a shortage BBy proprietary chemical cartridges, also made by Cepheid, that are needed to conduct COVID tests. Each test uses one cartridge.
News Navigation
Health experts say Africa is being priced out of the market. That's roughly double the concessionary rate secured for poorer countries, including Congo. Cepheid isn't breaching any contract by directing supplies to the U. But there was a pledge to set aside 1. That's a fraction of Cepheid's output. Yet less than a fifth of this total was delivered in the agreed period, from April to August, WHO data show. And shortages have continued since.
Ocurrencias para crear sonrisas.
By lateCepheid had still delivered less than a third. Many of the consortium countries are heavily dependent on GeneXpert machines. Reuters couldn't determine where the cartridges that Cepheid originally pledged to the consortium ended up in that April-August period. Or at what price they were sold.
Navigation menu
In response to questions, Cepheid said it has supplied COVID tests to over countries Epivemic, has raised production and is working hard to expand capacity further to meet demand that continues to be much higher than supply in every region. We have worked with the consortium and the WHO allocation model to be as fair and equitable as possible in the split of the available volumes, Cepheid said in a statement.
It noted the company supplied record numbers of TB tests to low and middle-income nations indespite the pandemic.
Cepheid didn't directly address the 1. Danaher has said in quarterly earnings that Cepheid's revenues have soared over the past year, and it is installing GeneXpert devices globally at a record rate. Bukavu's Provincial General Reference Hospital declined to comment about shortages affecting its ability to test.]
It is a pity, that now I can not express - there is no free time. I will be released - I will necessarily express the opinion on this question.
What words... super, a remarkable idea
Excuse for that I interfere … At me a similar situation. Let's discuss. Write here or in PM.
Can fill a blank...